Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0T1UJ
|
||||
| Former ID |
DAP001195
|
||||
| Drug Name |
Reteplase
|
||||
| Synonyms |
Retevase; Rapilysin (TN); Retavase (TN); Retevase (TN); Reteplase (USAN/INN)
|
||||
| Therapeutic Class |
Thrombolytic Agents
|
||||
| Formula |
C1736H2671N499O522S22
|
||||
| CAS Number |
CAS 133652-38-7
|
||||
| PubChem Substance ID | |||||
| SuperDrug ATC ID |
B01AD07
|
||||
| Target and Pathway | |||||
| Target(s) | Plasminogen | Target Info | Activator | [536348], [536795] | |
| PANTHER Pathway | Blood coagulation | ||||
| Plasminogen activating cascade | |||||
| PathWhiz Pathway | Coagulation | ||||
| WikiPathways | Complement and Coagulation Cascades | ||||
| Human Complement System | |||||
| Regulation of Insulin-like Growth Factor (IGF) Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | |||||
| Activation of Matrix Metalloproteinases | |||||
| Blood Clotting Cascade | |||||
| Dissolution of Fibrin Clot | |||||
| Folate Metabolism | |||||
| Vitamin B12 Metabolism | |||||
| Selenium Micronutrient Network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.